Assembly Biosciences, Inc.

Ownership Transactions Reported by 20 Insiders

Symbol
ASMB on Nasdaq
Industry
Pharmaceutical Preparations
Location
Two Tower Place, 7 Th Floor, South San Francisco, CA

Insiders trading volume in the past year

Assembly Biosciences, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Gilead Sciences, Inc. 10%+ Owner $100M +$20.1M +25.1% Aug 8, 2025
Alexander Schornstein 10%+ Owner $10.8M +$518K +5.03% Nov 22, 2024
John G. McHutchison Director $181K -$7.46K -3.96% Jun 5, 2025
William E. Delaney IV Chief Scientific Officer $165K Mar 29, 2025
Jason A. Okazaki CEO and President, Director $145K -$3.5K -2.35% Mar 29, 2025
Nicole S. White Chief Manufacturing Officer $115K -$2.59K -2.2% Mar 29, 2025
Michael P. Samar Chief Financial Officer $61.8K Jul 25, 2022
Michael Houghton Director $50K +$50K Jun 5, 2025
Jeanette M. Bjorkquist PFO and PAO $48.7K -$1.77K -3.51% Jun 16, 2025
Luisa M. Stamm Chief Medical Officer $32.3K Mar 29, 2022
Gina Consylman Director Jun 5, 2025
Anuj Gaggar Chief Medical Officer Mar 29, 2025
Anthony E. Altig Director Jun 5, 2025
William R. Ringo Director Jun 5, 2025
Lisa Johnson-Pratt Director Jun 5, 2025
Susan Mahony Director Jun 5, 2025
Myron Z. Holubiak Director May 20, 2021
Richard D. DiMarchi Director May 25, 2022
Robert Donald Cook II Director Mar 13, 2024
Tomas Cihlar Director Dec 7, 2023

Recent Insider Transactions by Companies or Individuals for Assembly Biosciences, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.